These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 6892491
1. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer. Forastiere AA, Crain SM, Callahan K, Van Echo D, Mattox D, Thant M, Von Hoff DD, Wiernik PH. Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491 [No Abstract] [Full Text] [Related]
2. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). Carey RW, Comis RL, Anbar D, Kennedy BJ, Capizzi RL, Shulman P, Booth BW, Green M, Raich PC. Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498 [No Abstract] [Full Text] [Related]
3. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. Budman DR, Forastiere A, Perloff M, Perry M, Aisner J, Weinberg V, Wood W. Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327 [No Abstract] [Full Text] [Related]
4. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma. Creagan ET, Schutt AJ, Ahmann DL, Green SJ. Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650 [Abstract] [Full Text] [Related]
9. Phase I study of aziridinylbenzoquinone (NSC 182986). Bedikian AY, Bodey GP, Burgess MA, Freireich EJ. Cancer Clin Trials; 1981 Jun; 4(4):459-63. PubMed ID: 7318128 [Abstract] [Full Text] [Related]
10. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans. Schilsky RL, Kelley JA, Ihde DC, Howser DM, Cordes RS, Young RC. Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028 [Abstract] [Full Text] [Related]
11. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia. Kamen BA, Holcenberg JS, Siegel SE. Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367 [No Abstract] [Full Text] [Related]
12. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung. Fuks JZ, Aisner J, Van Echo DA, Levitt M, Ihde DC, Carney D, Wiernik PH. Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094 [Abstract] [Full Text] [Related]
13. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer. Tan CT, Hancock CH, Mondora A, Hoffman NW. Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381 [Abstract] [Full Text] [Related]
16. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. Chan C, Bartolucci A, Brenner D, Presant C, Davila E, Carpenter J, Greco FA, Clamon G, Moore J. Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834 [No Abstract] [Full Text] [Related]
17. Phase II clinical trial of diaziquone in bronchogenic carcinoma. Chiuten DF, Umsawasdi T, Dhingra HM, Murphy WK, Spitzer G, Carr DT, Bodey GP, Valdivieso M. Cancer Treat Rep; 1985 Mar; 69(7-8):921-2. PubMed ID: 4016800 [No Abstract] [Full Text] [Related]
18. Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group. Lund B, Bramwell V, Renard J, Hansen HH, Dombernowsky P. Cancer Treat Rep; 1985 Mar; 69(3):339-40. PubMed ID: 3872170 [No Abstract] [Full Text] [Related]
19. Phase I-II diaziquone chemotherapy in brain tumors. Madajewicz S, Spaulding M, Bhimani S, Avellanosa A, DeLos Santos R, Perry A, Zeigler P, Kirshner J. Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706 [No Abstract] [Full Text] [Related]
20. Phase II study of diaziquone in patients with advanced carcinoma of the lung. Frytak S, Eagan RT, Creagan ET, Nichols WC. Cancer Treat Rep; 1984 Sep; 68(9):1193-4. PubMed ID: 6478455 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]